UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Mayo Clinic proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 8, pp. 996 - 1000
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Costs | United States - epidemiology | Neoplasms - economics | Humans | Patient Participation | Patient Advocacy | Antineoplastic Agents - economics | Neoplasms - epidemiology | Prescription Fees | Neoplasms - drug therapy | Antimitotic agents | Cancer patients | Patient outcomes | Economic aspects | Dosage and administration | Drug therapy | Antineoplastic agents | Index Medicus | Abridged Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2003, Volume 63, Issue 21, pp. 2324 - 2325
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2003, Volume 63, Issue 21, pp. 2325 - 2325
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Administration, Oral | Humans | Biological Availability | Vidarabine - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - therapeutic use | Vidarabine - administration & dosage | Vidarabine - analogs & derivatives | Antineoplastic Agents - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Vidarabine - therapeutic use | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 07/2016, Volume 128, Issue 3, pp. 325 - 330
Life Sciences & Biomedicine | Hematology | Science & Technology | Lymphoma - drug therapy | Pyrazoles - therapeutic use | Pyrimidines - therapeutic use | Humans | Drug Design | Clinical Trials as Topic | Purines - therapeutic use | Quinazolinones - therapeutic use | Lymphoma - mortality | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2011, Volume 29, Issue 14, pp. 1844 - 1854
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphoma - diagnosis | Humans | Hematopoietic Stem Cell Transplantation | Tomography, X-Ray Computed | Positron-Emission Tomography | Bone Marrow Examination | Lymphoma - therapy | Diagnostic Errors | Gallium Radioisotopes | Fluorodeoxyglucose F18 | Lymphoma - pathology | Neoplasm Staging | Thallium Radioisotopes | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1081 - 1093
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Survival Rate | Lymphoma, Non-Hodgkin - pathology | Neoplasm Recurrence, Local - pathology | Rituximab - administration & dosage | Bendamustine Hydrochloride - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Female | Aged | Neoplasm Staging | Drug Resistance, Neoplasm - drug effects | Lymphoma, Non-Hodgkin - drug therapy | Antimitotic agents | Monoclonal antibodies | Care and treatment | Lymphomas | Product development | Antineoplastic agents | Analysis | Index Medicus | Life Sciences | Cancer
Journal Article
7.
Full Text
Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
Journal of clinical oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 21, pp. 3525 - 3530
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Antigens, CD20 - immunology | Animals | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Monoclonal - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Drug Evaluation, Preclinical | Cytotoxicity, Immunologic | Lymphoma, B-Cell - drug therapy | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 04/2020, Volume 135, Issue 16, pp. 1308 - 1309
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2014, Volume 370, Issue 11, pp. 997 - 1007
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | General aspects | Pharmacology. Drug treatments | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Immunomodulators | Recurrence | Lymph Nodes - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Leukemia, Lymphocytic, Chronic, B-Cell - complications | Aged, 80 and over | Female | Kidney Diseases - complications | Purines - adverse effects | Purines - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Rituximab | Class Ia Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Quinazolinones - therapeutic use | Antibodies, Monoclonal, Murine-Derived - adverse effects | Quinazolinones - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Chronic lymphocytic leukemia | Care and treatment | Medical research | Chronic lymphatic leukemia | Chemotherapy | Renal function | Leukemia | Myelosuppression | Lymphatic leukemia | Kinases | Drug therapy | Survival | 1-Phosphatidylinositol 3-kinase | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 25, pp. 3061 - 3068
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Prognosis | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | DNA-Binding Proteins - analysis | Male | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Immunotherapy | Adolescent | Adult | Female | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Child | Central Nervous System Neoplasms - mortality | Lymphoma, Non-Hodgkin - drug therapy | Proto-Oncogene Proteins c-bcl-6 | Index Medicus | Hema16 | Hema13 | ORIGINAL REPORTS | To2
Journal Article
Seminars in nuclear medicine, ISSN 0001-2998, 01/2018, Volume 48, Issue 1, pp. 76 - 81
Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Hodgkin Disease - diagnostic imaging | Lymphoma, Large B-Cell, Diffuse - diagnostic imaging | Clinical Trials as Topic | Lymphoma - diagnostic imaging | Humans | Positron Emission Tomography Computed Tomography - methods | PET imaging | Lymphomas | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 05/2018, Volume 131, Issue 22, pp. 2408 - 2409
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2008, Volume 359, Issue 6, pp. 613 - 626
Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Antigens, CD20 - immunology | Antibodies, Monoclonal, Murine-Derived | Antibodies, Monoclonal - pharmacology | Humans | Rituximab | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Lymphoma, B-Cell - radiotherapy | B-Lymphocytes - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Immunotherapy | Antigens, Surface | Radioimmunotherapy - adverse effects | Lymphoma, B-Cell - drug therapy | Monoclonal antibodies | Complications and side effects | Dosage and administration | Non-Hodgkin's lymphomas | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article